Capstone Investment Advisors, LLC Amylyx Pharmaceuticals, Inc. Transaction History

Capstone Investment Advisors, LLC

  • $29.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024
BUY
$2.71 - $19.57 $162,827 - $1.18 Million
60,084 Added 300.42%
80,084 $227,000
Q4 2023

Feb 12, 2024
SELL
$12.07 - $18.46 $34,146 - $52,223
-2,829 Reduced 12.39%
20,000 $294,000
Q3 2023

Nov 13, 2023
BUY
$18.08 - $23.45 $412,748 - $535,340
22,829 New
22,829 $417,000
Q1 2023

May 09, 2023
BUY
$27.71 - $40.93 $281,256 - $415,439
10,150 New
10,150 $297,000

Others Institutions Holding AMLX

# of Institutions
139
Shares Held
46.5M
Call Options Held
226K
Put Options Held
909K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email